Biond Biologics, Ltd.

Industry

  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on Biond Biologics, Ltd.

Scrip

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January

Scrip

Deal Watch: Sanofi Teams Up With Biond On Novel Checkpoint Inhibitor

 
• By Joseph Haas, Alex Shimmings, and Kevin Grogan

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Backs Biond's IO Agent With Big